BrightPath Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.6%.

Top 17 shareholders own 12.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.14%	Rakuten Investment Management, Inc.	1,774,100	JP¥94.0m	133%	0.04%
1.71%	Macquarie Group, Ltd., Banking & Securities Investments	1,418,500	JP¥75.2m	84.6%	no data
1.55%	Evolution Capital Management LLC	1,283,000	JP¥68.0m	2.9%	0.65%
0.8%	Matsui Securities Co. Ltd., Asset Management Arm	661,000	JP¥35.0m	0.02%	0.14%
0.79%	au Kabucom Securities Co., Ltd., Asset Management Arm	651,300	JP¥34.5m	132%	0.16%
0.72%	Hiroshi Akeo	600,000	JP¥31.8m	0%	no data
0.59%	Takehiko Nakazato	490,000	JP¥26.0m	15.3%	no data
0.56%	Kazumi Araki	467,300	JP¥24.8m	0%	no data
0.54%	Mitsubishi UFJ Capital Co., Ltd.	450,000	JP¥23.9m	0%	0.13%
0.5%	SBI Holdings Inc., Asset Management Arm	412,994	JP¥21.9m	0%	0.01%
0.49%	Japan Securities Finance Co. Ltd., Asset Management Arm	408,600	JP¥21.7m	0%	no data
0.45%	Shunsuke Nakamura	373,000	JP¥19.8m	0%	no data
0.43%	Akira Nishimura	360,000	JP¥19.1m	0%	no data
0.43%	Kazuhiko Kaneko	355,300	JP¥18.8m	0%	no data
0.4%	Shinaaki Katsura	327,200	JP¥17.3m	0%	no data
0.29%	Kenichi Nagai	240,000	JP¥12.7m	0%	no data
0.22%	Akira Yamada	185,000	JP¥9.8m	0%	no data